Literature DB >> 15096804

Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.

Rao L Divi1, Vernon E Walker, Nancy A Wade, Kunio Nagashima, Steven K Seilkop, Mary Ellen Adams, Carol J Nesel, J Patrick O'Neill, Elaine J Abrams, Miriam C Poirier.   

Abstract

OBJECTIVE: Although most uninfected infants born to women infected with HIV-1 show no clinical evidence of mitochondrial compromise, mitochondrial dysfunction has been reported in children born to women receiving zidovudine and/or lamivudine during pregnancy. In this pilot study we examined mitochondrial integrity in HIV-1-uninfected infants born to HIV-1-infected women receiving Combivir during pregnancy.
DESIGN: : Samples of umbilical cord and cord blood were obtained from HIV-1-uninfected infants born to either HIV-1-infected women receiving Combivir therapy during pregnancy (n = 10) or HIV-1-uninfected women (n = 9).
METHODS: Mitochondrial morphological integrity was examined in umbilical cords (n = 16) by electron microscopy and mtDNA quantity was determined in DNA from cord blood (n = 18) and umbilical cord (n = 18) by PCR-chemiluminescence immunoassay detection.
RESULTS: In umbilical cords from six of nine infants born to HIV-1-infected mothers taking Combivir moderate to severe mitochondrial morphological damage was observed (P = 0.011), while none of seven unexposed infants showed similar damage. Compared to unexposed infants, statistically significant mtDNA depletion was observed in umbilical cord (P = 0.006) and cord blood (P = 0.003) from drug-exposed infants.
CONCLUSIONS: A cohort of HIV-1-uninfected Combivir-exposed infants with no clinical symptoms showed morphological and molecular evidence of mitochondrial damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096804     DOI: 10.1097/00002030-200404300-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  27 in total

Review 1.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.

Authors:  Miriam C Poirier; Alexander T Gibbons; Maria T Rugeles; Isabelle Andre-Schmutz; Stephane Blanche
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 3.  Complications of Treatment in Youth with HIV.

Authors:  Allison Ross Eckard; Sandra L Fowler; Julia C Haston; Terry C Dixon
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

4.  Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.

Authors:  A C Ross; T Leong; A Avery; M Castillo-Duran; H Bonilla; D Lebrecht; U A Walker; N Storer; D Labbato; A Khaitan; I Tomanova-Soltys; G A McComsey
Journal:  HIV Med       Date:  2011-11-21       Impact factor: 3.180

5.  Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.

Authors:  Abhinav Ajaykumar; Mayanne Zhu; Fatima Kakkar; Jason Brophy; Ari Bitnun; Ariane Alimenti; Hugo Soudeyns; Sara Saberi; Arianne Y K Albert; Deborah M Money; Hélène C F Côté
Journal:  J Infect Dis       Date:  2021-02-24       Impact factor: 5.226

6.  Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon.

Authors:  Jennifer Jao; Kathleen M Powis; Brian Kirmse; Chunli Yu; Fanny Epie; Emmanuel Nshom; Elaine J Abrams; Rhoda S Sperling; Derek Leroith; Mitchell E Geffner; Irwin J Kurland; Hélène C F Côté
Journal:  AIDS       Date:  2017-11-28       Impact factor: 4.177

7.  Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).

Authors:  Rao L Divi; Tracey L Einem; Sarah L Leonard Fletcher; Marie E Shockley; Maryanne M Kuo; Marisa C St Claire; Anthony Cook; Kunio Nagashima; Steven W Harbaugh; Jeffrey W Harbaugh; Miriam C Poirier
Journal:  Toxicol Sci       Date:  2010-08-11       Impact factor: 4.849

Review 8.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

9.  Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Authors:  Grace M Aldrovandi; Clara Chu; William T Shearer; Daner Li; Jan Walter; Bruce Thompson; Kenneth McIntosh; Marc Foca; William A Meyer; Belinda F Ha; Kenneth C Rich; Jack Moye
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

10.  Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.

Authors:  Grace A McComsey; Minhee Kang; Allison C Ross; Dirk Lebrecht; Elizabeth Livingston; Ann Melvin; Jane Hitti; Susan E Cohn; Ulrich A Walker
Journal:  HIV Clin Trials       Date:  2008 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.